Comparative Assessment of Sera from Individuals after S-Gene RNA-Based SARS-CoV-2 Vaccination with Spike-Protein-Based and Nucleocapsid-Based Serological Assays
Due to the beginning of vaccination against COVID-19, serological discrimination between vaccine-associated humoral response and serology-based surveillance of natural SARS-CoV-2 infections as well as breakthrough infections becomes an issue of relevance. Here, we assessed the differentiated effects...
Main Authors: | Anja Dörschug, Hagen Frickmann, Julian Schwanbeck, Elif Yilmaz, Kemal Mese, Andreas Hahn, Uwe Groß, Andreas E. Zautner |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/11/3/426 |
Similar Items
-
Comparison of Five Serological Assays for the Detection of SARS-CoV-2 Antibodies
by: Anja Dörschug, et al.
Published: (2021-01-01) -
Mild SARS-CoV-2 Illness Is Not Associated with Reinfections and Provides Persistent Spike, Nucleocapsid, and Virus-Neutralizing Antibodies
by: Charles F. Schuler, et al.
Published: (2021-10-01) -
Association between IgG responses against the nucleocapsid proteins of alphacoronaviruses and COVID-19 severity
by: Julius Nückel, et al.
Published: (2022-09-01) -
A comparative study of eight serological methods shows that spike protein-based ELISAs are the most accurate tests for serodiagnosing SARS-CoV-2 infections in cats and dogs
by: Carlos Diezma-Díaz, et al.
Published: (2023-01-01) -
Serum Level of Anti-Nucleocapsid, but Not Anti-Spike Antibody, Is Associated with Improvement of Long COVID Symptoms
by: Reka Varnai, et al.
Published: (2022-01-01)